Immunoglobulin Light (Heavy)-Chain Deposition Disease: From Molecular Medicine to Pathophysiology-Driven Therapy | American Society of Nephrology
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Light chain deposition disease - ppt download
Red Flag Presentations of Immunoglobulin Light Chain Amyloidosis in Patients With Multiple Myeloma - The ASCO Post
Multiple myeloma - ScienceDirect
AL - Amyloidosis Foundation
Kappa and Lambda Light Chains - The Myeloma Crowd
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All | HTML
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
Treatment of Immunoglobulin Light Chain Amyloidosis - Mayo Clinic Proceedings
The biology of immunoglobulin free light chains and kidney injury - Kidney International
Light Chain Deposition Disease | SpringerLink
The Heavy Chain Diseases: Clinical and Pathologic Features
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - Kidney International
New insights into the pathogenesis and treatment of heavy chain deposition disease - Kidney International
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? | Immunology
Prognostic and predictive biomarker developments in multiple myeloma | Journal of Hematology & Oncology | Full Text
Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment - Gertz - 2018 - American Journal of Hematology - Wiley Online Library
Monoclonal gammopathy of renal significance: Early diagnosis is key | Nefrología
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site